RIO BIOPHARMACEUTICALS, INC.

Lobbying Spend

—

Filings

Firms Hired

Active Period

2025–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	4	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
BALLARD PARTNERS	—	7

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
Health & Human Services, Dept of (HHS)	6
Commerce, Dept of (DOC)	2
Executive Office of the President (EOP)	2
HOUSE OF REPRESENTATIVES	2
SENATE	2
White House Office	2
Food & Drug Administration (FDA)	1

Most frequently reported lobbying issues

Issue Code	Description	Reports
Pharmacy	Pharmacy	7

RIO BIOPHARMACEUTICALS, INC. — Lobbying Disclosure | Poliscope